3-Oxa-9-azoniatricyclo[3.3.1.02,4]nonane,9- butyl-9-methyl-7-[(1-oxo-2-phenyl-2- propenyl)oxy]-,bromide,(1R,2â,4â,5R,7â)- (92714-23-3)
Identification |
Properties |
Safety Data |
|
 |
Other Product
- 3-Oxa-9-azoniatricyclo[3.3.1.02,4]nonane,9- butyl-7-[(2S)-3-hydroxy-1-oxo-2-phenylpropoxy]- 9-methyl-,bromide,(1R,2â,4â,5R,7â)-,mixt. with 3,6-dihydro-R-[(2-methylphenoxy)methyl]-1- (2H)-pyridineethanol hydrochloride and 3-methylbutyl R-[[2-(diethylamino)ethyl]amino]- benzeneacetate dihydrochloride
- 3-Oxa-9-azoniatricyclo(3.3.1.0(sup 2,4))nonane, 9-butyl-9-methyl-7-((1-oxo-2-propylpentyl)oxy)-, bromide, stereoisomer
- 3-Oxa-9-azoniatricyclo[3.3.1.02,4]nonane,9-butyl-7-[(2S)-3-hydroxy-1-oxo-2-phenylpropoxy]-9-methyl-, bromide (1:1), (1a,2b,4b,5a,7b)-
- 3-Oxa-9-azoniatricyclo(3.3.1.0(sup 2,4))nonane, 9-methyl-9-(1-methylethyl)-7-((1-oxo-2-propylpentyl)oxy)-, bromide, stereoisomer
- 3-Oxa-9-azoniatricyclo(3.3.1.0(sup 2,4))nonane, 9,9-dimethyl-7-((1-oxo-2-propylpentyl)oxy)-, bromide, (1-alpha,2-beta,4-beta,5-alpha,7-beta)-
- Benzeneacetic acid,R-(hydroxymethyl)-,(1R,2â,- 4â,5R,7â)-9-methyl-3-oxa-9-azatricyclo- [3.3.1.02,4]non-7-yl ester,(RS)-,hydrobromide,mixt. with 3,7-dihydro-1,3,7-trimethyl-1Hpurine- 2,6-dione,N,N-dimethyl-ç-phenyl-2- pyridinepropanamine (2Z)-2-butenedioate (1:1) and ethyl 4-aminobenzoate
- 9-butyl-7-{[(2S)-3-hydroxy-2-phenylpropanoyl]oxy}-9-methyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane bromide - 7-chloro-3-hydroxy-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one (1:1:1)
- Morphinan-6-one,4,5-epoxy-14-hydroxy-3- methoxy-17-methyl-,hydrochloride,(5R)-,mixt. with (RS)-R-[(1R)-1-(methylamino)ethyl]- benzenemethanol hydrochloride and (1R,2â,4â,5R,7â)-9-methyl-3-oxa-9- azatricyclo[3.3.1.02,4]non-7-yl (RS)-R-(hydroxymethyl)benzeneacetate hydrobromide
- 7-[(Hydroxy-2-thienyl-3-thienylacetyl)oxy]-9,9-diMethyl-3-Oxa-9-azoniatricyclo[3.3.1.02,4]nonane BroMide
- 3-Oxa-9-azoniatricyclo[3.3.1.02,4]nonane,9-ethyl-7-[(2S)-3-hydroxy-1-oxo-2-phenylpropoxy]-9-methyl-, bromide (1:1), (1a,2b,4b,5a,7b)-
- 3-OXA-9-AZONIATRICYCLO(3.3.1.02,4))NONANE, 9-BUTYL-7-(3-HYDROXY-1-OXO-2-PHENYLPROPOXY)-9-METHYL-, (7(S)-(1-,2-,4-,5-,7-))-, SALT WITH 1,2,3,6-TETRAHYDRO-1,3-DIMETHYL-2,6-DIOXO-7H-PURINE-7-PROPANESULFONATE, HYDRATE (2:2:5)
- (1R,5S)-7-{[hydroxy(dithiophen-2-yl)acetyl]oxy}-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane bromide hydrate (1:1:1)
- 9-butyl-7-[(3-hydroxy-2-phenylpropanoyl)oxy]-9-methyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane bromide - N~2~-benzoyl-N,N-dipropyl-alpha-glutamine (1:1:1)
- â-D-Glucopyranoside,(3â,7â,9â,10R,16â)-7- hydroxy-9-methyl-3-(â-D-xylopyranosyloxy)- 19-norlanosta-5,24-dien-16-yl,4-acetate
- 7H-Furo[3,2-g][1]benzopyran-7-one,2,3- dihydro-9-hydroxy-2-[1-[[6-O-[3-(4- hydroxyphenyl)-1-oxo-2-propenyl]-â-Dglucopyranosyl] oxy]-1-methylethyl]-
- â-D-Glucopyranoside,(3â,7â,9â,10R,16â)-3-[(3,- 4-di-O-acetyl-â-D-xylopyranosyl)oxy]-7- hydroxy-9-methyl-19-norlanosta-5,24-dien- 16-yl,6-acetate
- 24,25,26-Trinorolean-7-en-3-ol,5,9,13- trimethyl-,(3â,4â,5â,9â,10R,13R,14â)-
- 9,9-dimethyl-7-({2-phenyl-3-[(phenylcarbamoyl)oxy]propanoyl}oxy)-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane
- 3-Oxa-9-azoniatricyclo[3.3.1.02,4]nonane,7-[(2-hydroxy-2,2-di-2-thienylacetyl)oxy]-9,9-dimethyl-, bromide (1:1), (1a,2b,4b,5a,7b)-
- 3-Oxa-9-azoniatricyclo[3.3.1.02,4]nonane,7-[(2S)-3-hydroxy-1-oxo-2-phenylpropoxy]-9,9-dimethyl-, bromide (1:1), (1a,2b,4b,5a,7b)-